| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/BF01535722 |
| P698 | PubMed publication ID | 3123181 |
| P2093 | author name string | G Dotevall | |
| J Svedlund | |||
| I Sjödin | |||
| P2860 | cites work | Absence of therapeutic benefit from antacids or cimetidine in non-ulcer dyspepsia | Q68859523 |
| Controlled study of psychotherapy in chronic peptic ulcer disease | Q70036677 | ||
| An additional basic science for clinical medicine: IV. The development of clinimetrics | Q71124734 | ||
| A diagnostic score for the irritable bowel syndrome. Its value in the exclusion of organic disease | Q71354000 | ||
| Clomipramine treatment of obsessive-compulsive disorder. I. A controlled clinical trial | Q71389924 | ||
| Symptom complaints and health care seeking behavior in subjects with bowel dysfunction | Q71391621 | ||
| Clinical biostatistics. LIV. The biostatistics of concordance | Q71472627 | ||
| Controlled study of psychotherapy in irritable bowel syndrome | Q72560416 | ||
| Towards positive diagnosis of the irritable bowel | Q24674701 | ||
| A New Depression Scale Designed to be Sensitive to Change | Q29614720 | ||
| Learned illness behavior in patients with irritable bowel syndrome and peptic ulcer | Q34278084 | ||
| Dyspepsia: incidence of a non-ulcer disease in a controlled trial of ranitidine in general practice | Q34284355 | ||
| Is there a myoelectrical abnormality in the irritable colon syndrome? | Q34474638 | ||
| Gastrointestinal symptoms in the irritable bowel compared with peptic ulcer and inflammatory bowel disease | Q34526140 | ||
| Development of a schizophrenia scale sensitive to change | Q39240329 | ||
| Colonic myoelectric activity in the irritable bowel syndrome | Q40469325 | ||
| A comprehensive psychopathological rating scale | Q40543557 | ||
| A CPRS subscale to assess mental symptoms in workers exposed to jet fuel--some methodological considerations | Q40543562 | ||
| Clinical research in general medical journals: a 30-year perspective | Q41052946 | ||
| Bowel patterns among subjects not seeking health care. Use of a questionnaire to identify a population with bowel dysfunction | Q43324803 | ||
| Functional bowel disorders in apparently healthy people | Q43325684 | ||
| Registration of pain in a psychological perspective | Q43893269 | ||
| Symptom profiles in chronic peptic ulcer disease. A detailed study of abdominal and mental symptoms | Q45266757 | ||
| Upper gastrointestinal and mental symptoms in the irritable bowel syndrome | Q49041644 | ||
| Evidence that abnormal myoelectrical activity produces colonic motor dysfunction in the irritable bowel syndrome | Q67541316 | ||
| P433 | issue | 2 | |
| P921 | main subject | peptic ulcer disease | Q172941 |
| irritable bowel syndrome | Q838966 | ||
| P304 | page(s) | 129-134 | |
| P577 | publication date | 1988-02-01 | |
| P1433 | published in | Digestive Diseases and Sciences | Q15716711 |
| P1476 | title | GSRS--a clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease | |
| P478 | volume | 33 |
| Q33845395 | 'Gut health': a new objective in medicine? |
| Q64945027 | A 12-Week Pilot Exercise Program for Inactive Adults With Celiac Disease: Study Protocol. |
| Q91707115 | A Call for Research on the Prognostic Role of Follow-Up Histology in Celiac Disease: A Systematic Review |
| Q92282866 | A Dose-Escalation Study Demonstrates the Safety and Tolerability of Cellobiose in Healthy Subjects |
| Q35200499 | A Randomised, Cross-Over, Placebo-Controlled Study of Aloe vera in Patients with Irritable Bowel Syndrome: Effects on Patient Quality of Life. |
| Q54978721 | A Randomized Clinical Trial of Metformin to Treat Autosomal Dominant Polycystic Kidney Disease. |
| Q92967237 | A comparative study of the efficacy of NAXOZOL compared to celecoxib in patients with osteoarthritis |
| Q92714676 | A high prevalence of chronic gastrointestinal symptoms in adults with cystic fibrosis is detected using tools already validated in other GI disorders |
| Q64265404 | A novel role for the extracellular matrix glycoprotein-Tenascin-X in gastric function |
| Q34214731 | A pilot study of a randomized controlled trial of pragmatic eradication of Helicobactor pylori in primary care. |
| Q47877390 | A possible role for ghrelin, leptin, brain-derived neurotrophic factor and docosahexaenoic acid in reducing the quality of life of coeliac disease patients following a gluten-free diet. |
| Q33628957 | A preliminary evaluation of comparative effectiveness of riluzole in therapeutic regimen for irritable bowel syndrome |
| Q35555299 | A randomised, placebo controlled, comparative trial of the gastrointestinal safety and efficacy of AZD3582 versus naproxen in osteoarthritis |
| Q87498644 | A randomized, double-blind, placebo-controlled study of rebamipide for gastric mucosal injury taking aspirin with or without clopidogrel |
| Q37979183 | A review of rifaximin and bacterial overgrowth in poorly responsive celiac disease |
| Q36597231 | Absence of dyspeptic symptoms as a test of Helicobacter pylori eradication |
| Q36432155 | Accounting for the effect of GERD symptoms on patients' health-related quality of life: supporting optimal disease management by primary care physicians |
| Q92402034 | Acylated ghrelin levels were associated with depressive status, physical quality of life, endoscopic findings based on Kyoto classification in Japan |
| Q60931335 | Adipose Tissue-Derived Biomarkers of Intestinal Barrier Functions for the Characterization of Diarrhoea-Predominant IBS |
| Q42155477 | Altered Esophageal Mucosal Structure in Patients with Celiac Disease |
| Q72209129 | Altered esophageal pain threshold in irritable bowel syndrome |
| Q92999330 | An examination of naturopathic treatment of non-specific gastrointestinal complaints: comparative analysis of two cases |
| Q33781662 | Analysis of the gastrointestinal symptoms of uninvestigated dyspepsia and irritable bowel syndrome |
| Q46415429 | Aprepitant has Mixed Effects on Nausea and Reduces Other Symptoms in Patients With Gastroparesis and Related Disorders |
| Q51761741 | Are self-reported gastrointestinal symptoms among older adults associated with increased intestinal permeability and psychological distress? |
| Q39665261 | Are there any association between colonic diverticula and bowel symptoms?(neurogastroenterol motil 2015;27:333-338). |
| Q36991108 | Assessment of antigenemia assay for the diagnosis of cytomegalovirus gastrointestinal diseases in HIV-infected patients |
| Q54994214 | Assessment of colonic contents in patients with chronic constipation using MRI. |
| Q68591715 | Assessment of functional gastrointestinal disease: the bowel disease questionnaire |
| Q34601051 | Assessment of outcome in dyspepsia: has progress been made? |
| Q35756607 | Assessment of patient-reported outcome measures in the surgical treatment of patients with gastric cancer |
| Q64260254 | Association between digestive symptoms and sleep disturbance: a cross-sectional community-based study |
| Q34281657 | Asymptomatic intestinal amebiasis in Japanese HIV-1-infected individuals |
| Q34776287 | Auto-antibodies and their association with clinical findings in women diagnosed with microscopic colitis |
| Q35745054 | Best practice in symptom assessment: a review |
| Q50238330 | Bone Mineral Density in Boys Diagnosed with Autism Spectrum Disorder: A Case-Control Study |
| Q90331111 | Bowel dysfunction in survivors of gynaecologic malignancies |
| Q70511006 | Can symptoms associated with dysphagia be of discriminate value? |
| Q36987064 | Changes in salivary physiological stress markers induced by muscle stretching in patients with irritable bowel syndrome |
| Q45058025 | Changes in the prevalence of dyspepsia and Helicobacter pylori infection after 17 years: the Sørreisa gastrointestinal disorder study |
| Q48086136 | Characteristics and clinical relevance of postgastrectomy syndrome assessment scale (PGSAS)-45: newly developed integrated questionnaires for assessment of living status and quality of life in postgastrectomy patients |
| Q40405312 | Chronic Abdominal Pain and Symptoms 5 Years After Gastric Bypass for Morbid Obesity |
| Q33235286 | Chronic non-specific abdominal complaints in general practice: a prospective study on management, patient health status and course of complaints |
| Q36067256 | Classification of functional dyspepsia based on concomitant bowel symptoms |
| Q35862300 | Clinical Correlates of Mass Effect in Autosomal Dominant Polycystic Kidney Disease |
| Q64261077 | Clinical and Microbiological Effect of a Multispecies Probiotic Supplementation in Celiac Patients With Persistent IBS-type Symptoms: A Randomized, Double-Blind, Placebo-controlled, Multicenter Trial |
| Q34103860 | Clinical benefit of gluten-free diet in screen-detected older celiac disease patients |
| Q34137380 | Clinical presentations of gastric small gastrointestinal stromal tumors mimics functional dyspepsia symptoms |
| Q50350904 | Clinicopathological and immunological characteristics and outcome of concomitant coeliac disease and non-alcoholic fatty liver disease in adults: a large prospective longitudinal study |
| Q64068423 | Clostridium difficile Infection-Daily Symptoms (CDI-DaySyms™) questionnaire: psychometric characteristics and responder thresholds |
| Q42730653 | Colonic Transit Time and Gut Peptides in Adult Patients with Slow and Normal Colonic Transit Constipation. |
| Q41934629 | Combined analysis of the ORCHID and OCAY studies: does eradication of Helicobacter pylori lead to sustained improvement in functional dyspepsia symptoms? |
| Q36542684 | Comparative Study of 2 Different Questionnaires in Japanese Patients: The Quality of Life and Utility Evaluation Survey Technology Questionnaire (QUEST) Versus the Frequency Scale for the Symptoms of Gastroesophageal Reflux Disease Questionnaire (FS |
| Q96126122 | Comparison of clinical and pathological findings of patients undergoing elective colectomy for uncomplicated diverticulitis |
| Q58601993 | Comparison of clinical symptoms, gastric motility and fat intake in the early chronic pancreatitis patients with anti-acid therapy-resistant functional dyspepsia patients |
| Q92940639 | Congruency of Genetic Predisposition to Lactase Persistence and Lactose Breath Test |
| Q89641871 | Constipation in CKD |
| Q36682652 | Constipation, hard stools, fecal urgency, and incomplete evacuation, but not diarrhea is associated with diabetes and its related factors |
| Q32061158 | Continued (5-year) followup of a randomized clinical study comparing antireflux surgery and omeprazole in gastroesophageal reflux disease |
| Q35513239 | Continuous consumption of fermented milk containing Bifidobacterium bifidum YIT 10347 improves gastrointestinal and psychological symptoms in patients with functional gastrointestinal disorders |
| Q33865172 | Cost-effectiveness of internet-based cognitive behavior therapy for irritable bowel syndrome: results from a randomized controlled trial |
| Q38791641 | Current Status of Celiac Disease Drug Development |
| Q55624674 | Cytokine Profile and Immunoglobulin E-mediated Serological Food Hypersensitivity in Patients With Irritable Bowel Syndrome With Diarrhea. |
| Q92210349 | Daily Life Restrictions are Common and Associated with Health Concerns and Dietary Challenges in Adult Celiac Disease Patients Diagnosed in Childhood |
| Q36988715 | Daily consumption of a synbiotic yogurt decreases energy intake but does not improve gastrointestinal transit time: a double-blind, randomized, crossover study in healthy adults |
| Q55286544 | Decline in perception of acid regurgitation symptoms from gastroesophageal reflux disease in diabetes mellitus patients. |
| Q47117663 | Design and validation of a German version of the GSRS-IBS - an analysis of its psychometric quality and factorial structure |
| Q37162353 | Development and Validation of a Clostridium difficile Health-related Quality-of-Life Questionnaire. |
| Q81274132 | Development and psychometric evaluation of the patient assessment of upper gastrointestinal symptom severity index (PAGI-SYM) in patients with upper gastrointestinal disorders |
| Q33283471 | Development and psychometric testing of the Visual Analogue Scale for Irritable Bowel Syndrome (VAS-IBS). |
| Q47300323 | Development and validation of a cross-cultural questionnaire to evaluate nonulcer dyspepsia: the Porto Alegre Dyspeptic Symptoms Questionnaire (PADYQ). |
| Q46138993 | Development and validation of the irritable bowel syndrome scale under the system of quality of life instruments for chronic diseases QLICD-IBS: combinations of classical test theory and generalizability theory |
| Q37253647 | Development of a Symptom-Based Patient-Reported Outcome Instrument for Functional Dyspepsia: A Preliminary Conceptual Model and an Evaluation of the Adequacy of Existing Instruments. |
| Q34764154 | Development of an online library of patient-reported outcome measures in gastroenterology: the GI-PRO database. |
| Q90320882 | Diagnostic Accuracy of a Point-of-Care Test for Celiac Disease Antibody Screening among Infertile Patients |
| Q24200634 | Dietary interventions for recurrent abdominal pain (RAP) and irritable bowel syndrome (IBS) in childhood |
| Q24241687 | Dietary interventions for recurrent abdominal pain (RAP) and irritable bowel syndrome (IBS) in childhood |
| Q24242111 | Dietary interventions for recurrent abdominal pain (RAP) and irritable bowel syndrome (IBS) in childhood |
| Q34553955 | Dietary interventions for recurrent abdominal pain in childhood. |
| Q58759764 | Differential effects of dietary fibres on colonic barrier function in elderly individuals with gastrointestinal symptoms |
| Q42953652 | Differential responding of autonomic function to histamine H1 antagonism in irritable bowel syndrome |
| Q34379278 | Discriminant value of psychological distress, symptom profiles, and segmental colonic dysfunction in outpatients with severe idiopathic constipation |
| Q39766445 | Double tract reconstruction after distal gastrectomy for gastric cancer is effective in reducing reflux esophagitis and remnant gastritis with duodenal passage preservation |
| Q50519233 | Double-blind randomized controlled trial of rifaximin for persistent symptoms in patients with celiac disease |
| Q82132045 | Drug use by the elderly in general practice: effects on upper gastrointestinal symptoms |
| Q33162250 | Dumping syndrome following gastric bypass: validation of the dumping symptom rating scale |
| Q36912793 | Duodenal epithelial transport in functional dyspepsia: Role of serotonin. |
| Q47397035 | Effect of a Partially Hydrolysed Whey Infant Formula Supplemented with Starch and Lactobacillus reuteri DSM 17938 on Regurgitation and Gastric Motility |
| Q48018469 | Effect of an oats-containing gluten-free diet on symptoms and quality of life in coeliac disease. A randomized study |
| Q35533087 | Effect of body mass index and intra-abdominal fat measured by computed tomography on the risk of bowel symptoms |
| Q99546802 | Effect of different limb lengths on quality of life, eating patterns and gastrointestinal symptoms after Roux-en-Y gastric bypass in superobese patients: randomized study |
| Q33906991 | Effect of nortriptyline on symptoms of idiopathic gastroparesis: the NORIG randomized clinical trial |
| Q36081669 | Effects of Arabinoxylan and Resistant Starch on Intestinal Microbiota and Short-Chain Fatty Acids in Subjects with Metabolic Syndrome: A Randomised Crossover Study |
| Q43327978 | Effects of daikenchuto, a Japanese herb, on intestinal motility after total gastrectomy: a prospective randomized trial |
| Q33643624 | Effects of dietary supplementation with the green tea polyphenol epigallocatechin-3-gallate on insulin resistance and associated metabolic risk factors: randomized controlled trial |
| Q40728564 | Effects of disturbed sleep on gastrointestinal and somatic pain symptoms in irritable bowel syndrome. |
| Q48517995 | Effects of emptying function of remaining stomach on QOL in postgastrectomy patients |
| Q27026890 | Efficacy of mosapride plus proton pump inhibitors for treatment of gastroesophageal reflux disease: a systematic review |
| Q41435411 | Efficacy of rebamipide for low-dose aspirin-related gastrointestinal symptoms |
| Q36378825 | Electrogastrography associated with symptomatic changes after prokinetic drug treatment for functional dyspepsia. |
| Q52968367 | Electronic diaries and questionnaires: designing user interfaces that are easy for all patients to use. |
| Q33635123 | Endoscopy-Guided Evaluation of Duodenal Mucosal Permeability in Functional Dyspepsia |
| Q41685496 | Epigastric pain syndrome accompanying pancreatic enzyme abnormalities was overlapped with early chronic pancreatitis using endosonography |
| Q47389065 | Epitope-Specific Immunotherapy Targeting CD4-Positive T Cells in Celiac Disease: Safety, Pharmacokinetics, and Effects on Intestinal Histology and Plasma Cytokines with Escalating Dose Regimens of Nexvax2 in a Randomized, Double-Blind, Placebo-Contr |
| Q38785121 | Epitope-specific immunotherapy targeting CD4-positive T cells in coeliac disease: two randomised, double-blind, placebo-controlled phase 1 studies |
| Q53468964 | Esophageal function worsens with long duration of diabetes. |
| Q48067857 | Evaluation of QOL after proximal gastrectomy using a newly developed assessment scale (PGSAS-45). |
| Q37472718 | Evaluation of electrical activity after vagus nerve-preserving distal gastrectomy using multichannel electrogastrography |
| Q91844696 | Evaluation of lactulose, lactose, and fructose breath testing in clinical practice: A focus on methane |
| Q43140818 | Evaluation of periesophageal nerve injury after pulmonary vein isolation using the (13)C-acetate breath test. |
| Q48069181 | Evaluation of postgastrectomy symptoms after distal gastrectomy with Billroth-I reconstruction using the Postgastrectomy Syndrome Assessment Scale-45 (PGSAS-45). |
| Q35755677 | Evaluation of quality of life after laparoscopic surgery: evidence-based guidelines of the European Association for Endoscopic Surgery |
| Q45843069 | Evaluation of symptoms related to reflux esophagitis in patients with esophagogastrostomy after proximal gastrectomy |
| Q36243640 | Exposure-effect relationship of mycophenolic acid and prednisolone in adult patients with lupus nephritis |
| Q37624961 | Face-to-Face Cognitive-Behavioral Therapy for Irritable Bowel Syndrome: The Effects on Gastrointestinal and Psychiatric Symptoms. |
| Q37373294 | Factors affecting the quality of life of patients after gastrectomy as assessed using the newly developed PGSAS-45 scale: A nationwide multi-institutional study. |
| Q37714369 | Factors associated with residual gastroesophageal reflux disease symptoms in patients receiving proton pump inhibitor maintenance therapy |
| Q48078951 | Factors that minimize postgastrectomy symptoms following pylorus-preserving gastrectomy: assessment using a newly developed scale (PGSAS-45). |
| Q53086371 | Feasibility study of structured diagnosis methods for functional dyspepsia in Korean medicine clinics. |
| Q98466331 | Fecal Microbiota Signatures in Celiac Disease Patients With Poly-Autoimmunity |
| Q37122207 | Fermented Milk Containing Lactobacillus casei Strain Shirota Preserves the Diversity of the Gut Microbiota and Relieves Abdominal Dysfunction in Healthy Medical Students Exposed to Academic Stress |
| Q92978813 | Fermented milk containing Lactobacillus paracasei and Glycyrrhiza glabra has a beneficial effect in patients with Helicobacter pylori infection: A randomized, double-blind, placebo-controlled study |
| Q93077440 | Four weeks of probiotic supplementation reduces GI symptoms during a marathon race |
| Q85856131 | Functional Advantages of Proximal Gastrectomy with Jejunal Interposition Over Total Gastrectomy with Roux-en-Y Esophagojejunostomy for Early Gastric Cancer |
| Q33636702 | Functional dyspepsia symptom resolution after Helicobacter pylori eradication with two different regimens |
| Q38690133 | Functional implications of microbial and viral gut metagenome changes in early stage L-DOPA-naïve Parkinson's disease patients. |
| Q34130301 | Gastric bypass with long alimentary limb or long pancreato-biliary limb--long-term results on weight loss, resolution of co-morbidities and metabolic parameters |
| Q37133096 | Gastrointestinal Symptoms in Celiac Disease Patients on a Long-Term Gluten-Free Diet |
| Q89560972 | Gastrointestinal Tolerance and Microbiome Response to Snacks Fortified with Pea Hull Fiber: A Randomized Trial in Older Adults |
| Q39301209 | Gastrointestinal symptom severity in irritable bowel syndrome, inflammatory bowel disease and the general population |
| Q43365999 | Gastrointestinal symptomatic outcome after laparoscopic Roux-en-Y gastric bypass |
| Q33903641 | Gastrointestinal symptoms in patients undergoing peritoneal dialysis: multivariate analysis of correlated factors |
| Q34093902 | Gastrointestinal symptoms: a comparison between patients undergoing peritoneal dialysis and hemodialysis |
| Q33818667 | Gender Differences in Serotonin Signaling in Patients with Diarrhea-predominant Irritable Bowel Syndrome |
| Q64068367 | Gluten immunogenic peptide excretion detects dietary transgressions in treated celiac disease patients |
| Q93012243 | Glycemic response to low sugar apple juice treated with invertase, glucose oxidase and catalase |
| Q39251211 | Green-lipped mussel (Perna canaliculus) extract efficacy in knee osteoarthritis and improvement in gastrointestinal dysfunction: a pilot study |
| Q44590836 | Green-lipped mussel extract (Perna canaliculus) and glucosamine sulphate in patients with knee osteoarthritis: therapeutic efficacy and effects on gastrointestinal microbiota profiles |
| Q89530606 | Group cognitive behavioural therapy (GCBT) versus treatment as usual (TAU) in the treatment of irritable bowel syndrome (IBS): a study protocol for a randomized controlled trial |
| Q91673342 | Gut microbiota composition during a 12-week intervention with delayed-release dimethyl fumarate in multiple sclerosis - a pilot trial |
| Q64058071 | Haemorheological and haemostatic alterations in coeliac disease and inflammatory bowel disease in comparison with non-coeliac, non-IBD subjects (HERMES): a case-control study protocol |
| Q45773425 | Half-dose rabeprazole has an equal efficacy to standard-dose rabeprazole on endoscopic submucosal dissection-induced ulcer |
| Q80359669 | Health economic evaluation of therapeutic strategies in patients with idiopathic achalasia: results of a randomized trial comparing pneumatic dilatation with laparoscopic cardiomyotomy |
| Q34030004 | Health-related quality of life and associated psychosocial factors in irritable bowel syndrome: a review |
| Q36022875 | Health-related quality of life and hospital costs following esophageal resection: a prospective cohort study. |
| Q24806515 | Health-related quality of life improves with treatment-related GERD symptom resolution after adjusting for baseline severity |
| Q44865253 | Health-related quality of life in primary care patients with gastroesophageal reflux disease |
| Q44079339 | Helicobacter pylori eradication ameliorates symptoms and improves quality of life in patients on long-term acid suppression. A large prospective study in primary care |
| Q39368604 | Helicobacter pylori infection in patients with erosive esophagitis is associated with rapid heartburn relief and lack of relapse after treatment with pantoprazole. |
| Q74301110 | Helicobacter pylori test-and-eradicate versus prompt endoscopy for management of dyspeptic patients: a randomised trial |
| Q79073785 | High rate of gastrointestinal symptoms in celiac patients living on a gluten-free diet: controlled study |
| Q33722993 | Higher blood glucose level associated with body mass index and gut microbiota in elderly people |
| Q37843833 | Hydrogen ion changes and contractile behavior in the perfused rat heart |
| Q36199148 | Hypertension and concomitant arteriosclerotic diseases are risk factors for colonic diverticular bleeding: a case-control study |
| Q39410583 | Impact of combined therapy with alpha-lipoic and ursodeoxycolic acid on nonalcoholic fatty liver disease: double-blind, randomized clinical trial of efficacy and safety. |
| Q42637441 | Impact of complete gastric fundus mobilization on outcome after laparoscopic total fundoplication |
| Q34377196 | Impact of eating attitude and impairment of physical quality of life between tertiary clinic and primary clinic functional dyspepsia outpatients in Japan |
| Q34504510 | Impact of functional dyspepsia on quality of life and health care consumption after cessation of antisecretory treatment. A multicentre 3-month follow-up study |
| Q87369678 | Impaired epithelial integrity in the duodenal mucosa in early stages of celiac disease |
| Q53398797 | Improved quality of life with jejunal pouch reconstruction after total gastrectomy. |
| Q37356200 | Improving the well-being of men by Evaluating and Addressing the Gastrointestinal Late Effects (EAGLE) of radical treatment for prostate cancer: study protocol for a mixed-method implementation project |
| Q36699214 | Influence of percutaneous local therapy for hepatocellular carcinoma on gastric function |
| Q46573174 | Inhibition of microsomal triglyceride transfer protein alone or with ezetimibe in patients with moderate hypercholesterolemia |
| Q64286703 | Intraoperative Neurophysiologic Testing of the Perigastric Vagus Nerve Branches to Evaluate Viability and Signals along Nerve Pathways during Gastrectomy |
| Q27010213 | Irritable bowel syndrome |
| Q91610847 | Irritable bowel syndrome-like symptoms and health related quality of life two years after Roux-en-Y gastric bypass - a prospective cohort study |
| Q27687723 | Irritable bowel syndrome. |
| Q35727103 | Irritable bowel syndrome: dietary interventions. |
| Q37410679 | Lactobacillus reuteri in management of Helicobacter pylori infection in dyspeptic patients: a double-blind placebo-controlled randomized clinical trial |
| Q42691070 | Laparoscopic Rosetti fundoplication |
| Q84866096 | Laparoscopy-assisted proximal gastrectomy with sentinel node mapping for early gastric cancer |
| Q35655989 | Larazotide acetate for persistent symptoms of celiac disease despite a gluten-free diet: a randomized controlled trial. |
| Q98774540 | Letter: prevalence and patterns of gastrointestinal symptoms in a large Western cohort of patients with COVID-19 |
| Q48077310 | Long-term quality-of-life comparison of total gastrectomy and proximal gastrectomy by postgastrectomy syndrome assessment scale (PGSAS-45): a nationwide multi-institutional study |
| Q92704851 | Low FODMAP Diet: Evidence, Doubts, and Hopes |
| Q93355597 | Low FODMAP diet in Egyptian patients with Crohn's disease in remission phase with functional gastrointestinal symptoms |
| Q35803673 | Management of Helicobacter pylori eradication--the influence of structured counselling and follow-up |
| Q37829959 | Measurement and interpretation of patient-reported outcomes in surgery: an opportunity for improvement |
| Q91685604 | Measuring Diet Intake and Gastrointestinal Symptoms in Irritable Bowel Syndrome: Validation of the Food and Symptom Times Diary |
| Q53488373 | Measuring change in quality of life in response to Helicobacter pylori eradication in peptic ulcer disease: the QOLRAD. |
| Q73614110 | Measuring outcomes in surgical patients |
| Q39404704 | Measuring symptom distress and health-related quality of life in clinical trials of gastroesophageal reflux disease treatment: further validation of the Gastroesophageal Reflux Disease Symptom Assessment Scale (GSAS). |
| Q39826545 | Measuring symptoms in the irritable bowel syndrome: development of a framework for clinical trials |
| Q38223290 | Measuring the symptoms of pediatric constipation and irritable bowel syndrome with constipation: expert commentary and literature review |
| Q24236717 | Medical versus surgical management for gastro-oesophageal reflux disease (GORD) in adults |
| Q55383790 | Migalastat improves diarrhea in patients with Fabry disease: clinical-biomarker correlations from the phase 3 FACETS trial. |
| Q44709023 | Mizoribine versus mycophenolate mofetil in combination therapy with tacrolimus for de novo kidney transplantation: evaluation of efficacy and safety |
| Q51549410 | Motilin- and neuropeptide Y-like immunoreactivity in a psychophysiological stress experiment on patients with functional dyspepsia. |
| Q43331608 | Multi-Dimensional Gastrointestinal Symptom Severity Index: Validation of a Brief GI Symptom Assessment Tool |
| Q26799068 | Non-celiac gluten sensitivity: Time for sifting the grain |
| Q58605352 | Noninvasive biomarkers of gut barrier function identify two subtypes of patients suffering from diarrhoea predominant-IBS: a case-control study |
| Q40781407 | Number of Gastrointestinal Symptoms is a Useful Means of Identifying Patients with Cancer for Dysphagia |
| Q64122368 | Nutrient drink test: A promising new tool for irritable bowel syndrome diagnosis |
| Q48051563 | Optimal Roux-en-Y reconstruction after distal gastrectomy for early gastric cancer as assessed using the newly developed PGSAS-45 scale |
| Q50026308 | Outcome measures in coeliac disease trials: the Tampere recommendations. |
| Q43329585 | Outcomes from treating bile acid malabsorption using a multidisciplinary approach |
| Q26752745 | Pain Assessment--Can it be Done with a Computerised System? A Systematic Review and Meta-Analysis |
| Q36079695 | Patient reported outcomes in gastroesophageal reflux disease: an overview of available measures |
| Q35435130 | Patient-reported outcomes for irritable bowel syndrome are associated with patients' severity ratings of gastrointestinal symptoms and psychological factors |
| Q36817391 | Patient-reported outcomes in gastroenterology: clinical and research applications |
| Q37003809 | Pattern of alcohol consumption and its effect on gastrointestinal symptoms in inflammatory bowel disease |
| Q42716571 | Percutaneous local therapies for hepatocellular carcinoma impair gastric function |
| Q82023077 | Perfectionism underlying psychological background correlated with the symptoms of functional dyspepsia |
| Q41190000 | Persistent Intraepithelial Lymphocytosis in Celiac Patients Adhering to Gluten-Free Diet Is Not Abolished Despite a Gluten Contamination Elimination Diet |
| Q38927580 | Pharmacological interventions for recurrent abdominal pain in childhood. |
| Q34848481 | Pilot study of Biomarkers for predicting effectiveness of ramosetron in diarrhea-predominant irritable bowel syndrome: expression of S100A10 and polymorphisms of TPH1 |
| Q53204788 | Pneumatic dilatation or laparoscopic cardiomyotomy in the management of newly diagnosed idiopathic achalasia. Results of a randomized controlled trial. |
| Q41042345 | Predictive factors for body weight loss and its impact on quality of life following gastrectomy |
| Q40881488 | Predictors and Significance of Incomplete Mucosal Recovery in Celiac Disease After 1 Year on a Gluten-Free Diet. |
| Q34696026 | Predictors of persistent symptoms and reduced quality of life in treated coeliac disease patients: a large cross-sectional study |
| Q89224623 | Prevalence, Severity and Potential Nutritional Causes of Gastrointestinal Symptoms during a Marathon in Recreational Runners |
| Q37246167 | Probiotic administration among free-living older adults: a double blinded, randomized, placebo-controlled clinical trial. |
| Q54944795 | Prognosis of Dermatitis Herpetiformis Patients with and without Villous Atrophy at Diagnosis. |
| Q44316637 | Prospective randomized trial of laparoscopic (transabdominal preperitoneal) vs open (mesh) repair for bilateral and recurrent inguinal hernia |
| Q38609525 | Protocol for a pilot randomised controlled trial of metformin in pre-diabetes after kidney transplantation: the Transplantation and Diabetes (Transdiab) study |
| Q34756783 | Proton pump inhibitor step-down therapy for GERD: a multi-center study in Japan |
| Q80036132 | Proton pump inhibitors improve acid-related dyspepsia in gastroesophageal reflux disease patients |
| Q49638276 | Psychological distress, iron deficiency, active disease and female gender are independent risk factors for fatigue in patients with ulcerative colitis |
| Q24791343 | Psychometric validation of the German translation of the Gastrointestinal Symptom Rating Scale (GSRS) and Quality of Life in Reflux and Dyspepsia (QOLRAD) questionnaire in patients with reflux disease |
| Q35894914 | Quality of life after esophageal surgery |
| Q37714371 | Quality of life after total vs distal gastrectomy with Roux-en-Y reconstruction: Use of the Postgastrectomy Syndrome Assessment Scale-45. |
| Q34798408 | Quality of life and healthcare resource in patients receiving opioids for chronic pain: a review of the place of oxycodone/naloxone |
| Q37246903 | Quality of life and symptomatic response to gastric neurostimulation for gastroparesis |
| Q35745042 | Quality of life assessment in gastro-oesophageal reflux disease |
| Q58918131 | Quality of life in functional dyspepsia |
| Q43696884 | Quality of life in patients with subjective food hypersensitivity: applicability of the 10-item short form of the Nepean Dyspepsia Index |
| Q34001406 | Quality of life measurement in gastrointestinal and liver disorders |
| Q26774542 | Quality of life: A critical outcome for all surgical treatments of gastric cancer |
| Q53649202 | Quality-of-life assessments in evaluation of laparoscopic Rosetti fundoplication |
| Q37904827 | Questionnaire based gastroesophageal reflux disease (GERD) assessment scales |
| Q37432995 | Randomized clinical trial: the clinical effects of herb-partitioned moxibustion in patients with diarrhoea-predominant irritable bowel syndrome |
| Q50574436 | Rates of dyspepsia one year after Helicobacter pylori screening and eradication in a Danish population |
| Q46721365 | Reactive increase in gastric mucus secretion is an adaptive defense mechanism against low-dose aspirin-induced gastropathy |
| Q92234614 | Reduction in IBS symptom severity is not paralleled by improvement in quality of life in patients with irritable bowel syndrome |
| Q40920977 | Referral of Asian patients to a GI clinic. |
| Q93355448 | Referrals to a tertiary hospital: A window into clinical management issues in functional gastrointestinal disorders |
| Q43293550 | Relationship between low-dose aspirin-induced gastric mucosal injury and intragastric pH in healthy volunteers |
| Q53292385 | Reliability and validity of a new scale to assess postoperative dysfunction after resection of upper gastrointestinal carcinoma. |
| Q53583008 | Reliability and validity of the Gastrointestinal Symptom Rating Scale in patients with gastroesophageal reflux disease. |
| Q36389413 | Rikkunshi-to attenuates adverse gastrointestinal symptoms induced by fluvoxamine |
| Q64090104 | Role of Probiotics in Eradication: Lessons from a Study of Strains DSM 17938 and ATCC PTA 6475 (Gastrus®) and a Proton-Pump Inhibitor |
| Q48888802 | Roux-en-Y reconstruction is superior to billroth I reconstruction in reducing reflux esophagitis after distal gastrectomy: special relationship with the angle of his. |
| Q34675807 | S100A expression and interleukin-10 polymorphisms are associated with ulcerative colitis and diarrhea predominant irritable bowel syndrome |
| Q93169370 | Safety and efficacy of AMG 714 in adults with coeliac disease exposed to gluten challenge: a phase 2a, randomised, double-blind, placebo-controlled study |
| Q35036054 | Safety and immunomodulatory effects of three probiotic strains isolated from the feces of breast-fed infants in healthy adults: SETOPROB study. |
| Q48190791 | Sarcopenia during neoadjuvant therapy for oesophageal cancer: characterising the impact on muscle strength and physical performance. |
| Q55293445 | Self-Reported Fractures in Dermatitis Herpetiformis Compared to Coeliac Disease. |
| Q30657156 | Senior orienteering athletes as a model of healthy aging: a mixed-method approach |
| Q97884644 | Severity of postgastrectomy syndrome and quality of life after advanced gastric cancer radical gastrectomy |
| Q79991367 | Sex and gender in irritable bowel syndrome |
| Q43801369 | Short-term, daily intake of yogurt containing Bifidobacterium animalis ssp. lactis Bf-6 (LMG 24384) does not affect colonic transit time in women |
| Q82963897 | Small bowel injury induced by selective cyclooxygenase-2 inhibitors: a prospective, double-blind, randomized clinical trial comparing celecoxib and meloxicam |
| Q92375514 | Soluble fibre supplementation with and without a probiotic in adults with asthma: A 7-day randomised, double blind, three way cross-over trial |
| Q42934168 | Study design considerations for irritable bowel syndrome clinical trials. |
| Q34378436 | Suggestion of new possibilities in approaching individual variability in appetite through constitutional typology: a pilot study |
| Q47800304 | Supportive nutrition on recovery of metabolism, nutritional state, health-related quality of life, and exercise capacity after major surgery: a randomized study |
| Q34268284 | Symptom and health-related quality-of-life measures for use in selected gastrointestinal disease studies: a review and synthesis of the literature |
| Q35657978 | Symptomatic change and gastrointestinal quality of life after pancreatectomy |
| Q71050063 | Symptoms and Helicobacter pylori infection in children |
| Q74290822 | Symptoms associated with gastroesophageal reflux disease: development of a questionnaire for use in clinical trials |
| Q64264125 | Symptoms compatible with functional bowel disorders are common in patients with quiescent ulcerative colitis and influence the quality of life but not the course of the disease |
| Q35537792 | Symptoms, acid exposure and motility in patients with Barrett's esophagus |
| Q35344220 | Systematic review and meta-analysis of the proportion of Campylobacter cases that develop chronic sequelae |
| Q26781040 | Systematic review on quality of life outcomes after gastrectomy for gastric carcinoma |
| Q39336032 | Tegaserod for dyspepsia and reflux symptoms in patients with chronic constipation: an exploratory open-label study |
| Q57808639 | Ten years of follow-up of bilio-intestinal bypass: is malabsorption necessary for long-term metabolic results? |
| Q89769935 | The ALERT-B questionnaire: A screening tool for the detection of gastroenterological late effects after radiotherapy for prostate cancer |
| Q99549054 | The Effects of Metformin on the Gut Microbiota of Patients with Type 2 Diabetes: A Two-Center, Quasi-Experimental Study |
| Q92028566 | The Impact of Pectin Supplementation on Intestinal Barrier Function in Healthy Young Adults and Healthy Elderly |
| Q33852094 | The Long-Term Consumption of Oats in Celiac Disease Patients Is Safe: A Large Cross-Sectional Study |
| Q61989954 | The Mayo Dysphagia Questionnaire-30: Documentation of Reliability and Validity of a Tool for Interventional Trials in Adults with Esophageal Disease |
| Q64253086 | The Reduction in Gastric Atrophy after Eradication Is Reduced by Treatment with Inhibitors of Gastric Acid Secretion |
| Q55080500 | The TPH1 rs211105 gene polymorphism affects abdominal symptoms and quality of life of diarrhea-predominant irritable bowel syndrome. |
| Q48488314 | The development of a new measure of quality of life in the management of gastro-oesophageal reflux disease: the Reflux questionnaire |
| Q24795125 | The diagnostic value of endoscopy and Helicobacter pylori tests for peptic ulcer patients in late post-treatment setting |
| Q36679730 | The economic and quality-of-life benefits of Helicobacter pylori eradication in chronic duodenal ulcer disease--a community-based study |
| Q64068720 | The effect of 'Zesy002' kiwifruit ( var. ) on gut health function: a randomised cross-over clinical trial |
| Q55282714 | The effects of Bifidobacterium animalis ssp. lactis B94 on gastrointestinal wellness in adults with Prader-Willi syndrome: study protocol for a randomized controlled trial. |
| Q37550508 | The effects of Lactobacillus plantarum on small intestinal barrier function and mucosal gene transcription; a randomized double-blind placebo controlled trial |
| Q34573812 | The effects of fluorouracil, epirubicin, and cyclophosphamide (FEC60) on the intestinal barrier function and gut peptides in breast cancer patients: an observational study. |
| Q43365428 | The efficacy of a low-fat diet to manage the symptoms of bile acid malabsorption - outcomes in patients previously treated for cancer |
| Q57165013 | The extracellular matrix glycoprotein tenascin-X regulates peripheral sensory and motor neurones |
| Q36128773 | The health-related quality of life and economic burden of constipation |
| Q47734941 | The holistic management of consequences of cancer treatment by a gastrointestinal and nutrition team: a financially viable approach to an enormous problem? |
| Q58710660 | The impact of Helicobacter pylori infection, eradication therapy and probiotic supplementation on gut microenvironment homeostasis: An open-label, randomized clinical trial |
| Q41654535 | The impact of abuse and mood on bowel symptoms and health-related quality of life in irritable bowel syndrome (IBS). |
| Q35150984 | The impact of gastroesophageal reflux disease on quality of life |
| Q43226840 | The prokinetic effect of mosapride citrate combined with omeprazole therapy improves clinical symptoms and gastric emptying in PPI-resistant NERD patients with delayed gastric emptying |
| Q99565504 | The prophylactic effects of BIFICO on the antibiotic-induced gut dysbiosis and gut microbiota |
| Q39383297 | The selective serotonin reuptake inhibitor fluoxetine does not change rectal sensitivity and symptoms in patients with irritable bowel syndrome: a double blind, randomized, placebo-controlled study |
| Q93032432 | The study evaluating the effect of probiotic supplementation on the mental status, inflammation, and intestinal barrier in major depressive disorder patients using gluten-free or gluten-containing diet (SANGUT study): a 12-week, randomized, double-b |
| Q37313755 | The ties that bind: perceived social support, stress, and IBS in severely affected patients |
| Q36547357 | Therapeutic strategies for functional dyspepsia and the introduction of the Rome III classification |
| Q43319646 | Tolerance and safety of the potentially probiotic strain Lactobacillus rhamnosus PRSF-L477: a randomised, double-blind placebo-controlled trial in healthy volunteers. |
| Q64983006 | Transplantation and diabetes (Transdiab): a pilot randomised controlled trial of metformin in impaired glucose tolerance after kidney transplantation. |
| Q33619652 | Treating Helicobacter pylori infection in primary care patients with uninvestigated dyspepsia: the Canadian adult dyspepsia empiric treatment-Helicobacter pylori positive (CADET-Hp) randomised controlled trial |
| Q81906149 | Treatment effects of partially hydrolyzed guar gum on symptoms and quality of life of patients with irritable bowel syndrome. A multicenter randomized open trial |
| Q48059474 | Treatment of achalasia with laparoscopic myotomy or pneumatic dilatation: long-term results of a prospective, randomized study |
| Q54590744 | Trypsin activity and bile acid concentrations in the esophagus after distal gastrectomy. |
| Q64899464 | Unrecognised coeliac disease among men and women undergoing fertility treatment: A screening study. |
| Q37328688 | Upper Gastrointestinal Symptoms Predictive of Candida Esophagitis and Erosive Esophagitis in HIV and Non-HIV Patients: An Endoscopy-Based Cross-Sectional Study of 6011 Patients |
| Q24794676 | Validation and results of a questionnaire for functional bowel disease in out-patients |
| Q45977783 | Validation of Spanish language dyspepsia questionnaire. |
| Q79787955 | Validation of the Japanese version of the Rome II modular questionnaire and irritable bowel syndrome severity index |
| Q35993830 | Weight and Glucose Reduction Observed with a Combination of Nutritional Agents in Rodent Models Does Not Translate to Humans in a Randomized Clinical Trial with Healthy Volunteers and Subjects with Type 2 Diabetes |
| Q80024975 | [Burden of gastroesophageal reflux disease. Evidence from a recent methodological study in Spain] |
| Q77197331 | [Dyspepsia-related quality of life. Spanish adaptation and validation of the questionnaire Dyspepsia-Related Health Scale] |
| Q75300711 | [Evaluation of quality of life in digestive diseases] |
| Q35961488 | β2-1 Fructan supplementation alters host immune responses in a manner consistent with increased exposure to microbial components: results from a double-blinded, randomised, cross-over study in healthy adults. |
Search more.